ACTITHERA NORWAY AS
Developing precision radioligand therapies to treat difficult cancer cases.
Yleiskatsaus
- 10
- Työntekijät
- Tuntematon
- Liikevaihto
- 2025
- Perustettu
Avainpäättäjät
John Crowley
Independent Director
Igor Mochalkin
Vice President of Discovery Technologies
Libuse Tauchmanova
Vice President of Global Clinical Development
Paul Scola
Senior Vice President of Chemistry
+10 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Actithera is a biotechnology company founded in 2021 that focuses on developing next-generation radioligand therapies for cancer treatment. Their proprietary chemistry platform is designed to maximize radiation delivery to tumors while minimizing exposure to healthy tissues. By utilizing covalent ch...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- Aksjeselskap
- ALV-numero
- Tuntematon
Päättäjät
14 yhteystietoa FunnelfeedrissäJohn Crowley
Independent Director
Igor Mochalkin
Vice President of Discovery Technologies
Libuse Tauchmanova
Vice President of Global Clinical Development
Paul Scola
Senior Vice President of Chemistry
Jacques Moisan
Vice President of Biology & Translational Science
Steven Kelly
Chief Executive Officer and Director
Dimitrios Mantzilas
Chief Technology Officer & Site Head for Oslo Actithera AS
Berna Polack
Vice President of Global Clinical Affairs
Darshan Dalal
Chief Medical Officer
Torgeir Vaage
Acting Chief Financial Officer
Juergen Fleck
Vice President of Global Clinical Operations
Beatrice Brunkhorst
Head of Research & Development Operations and Program Management
Briggs Morrison
Chair of the Board
Hyelim Cho
Vice President Chief of Staff & Head of Strategy
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
NUCLITHERA AS
9 työntekijätDeveloping targeted alpha and beta emitters for metastatic cancer treatment.
Tetrakit Technologies ApS
10 työntekijätDeveloping innovative radiopharmaceuticals using advanced click chemistry for oncology.
SACRA Therapeutics AB
0 työntekijätSACRA pioneers novel RNA-targeting therapies for incurable cancers.
CURASIGHT A/S
3 työntekijätInnovative Danish biotech company developing targeted radiopharmaceutical cancer theranostics solutions.
Beactica Therapeutics AB
5 työntekijätPrecision medicine company developing novel therapeutics via targeted protein degradation.
Selaa lisää
Kysymyksiä yrityksestä ACTITHERA NORWAY AS
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo